Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms. 2004

Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
Merck Research Laboratories, San Diego, 3535 General Atomics Court, San Diego, CA 92121, USA.

Glucuronide conjugation of xenobiotics containing a carboxylic acid moiety represents an important metabolic pathway for these compounds in humans. Several human UDP-glucuronosyltransferases (UGTs) have been shown to catalyze the formation of acyl-glucuronides, including UGT2B7, UGT1A3, and UGT1A9. In this study, recombinant expressed UGT isoforms were investigated with many structurally related carboxylic acid analogues, and the UGT rank order for catalyzing the glucuronidation of carboxylic acids was UGT2B7?UGT1A3 approximately UGT1A9. Despite being a poor substrate with UGT1A3, coumarin-3-carboxylic acid was not a substrate for any other UGT isoform tested in this study, suggesting that it could be a specific substrate for UGT1A3. Interestingly, UGT1A7 and UGT1A10 also react with several carboxylic acid aglycones. Kinetic analysis showed that UGT2B7 exhibits much higher glucuronidation efficiency (Vmax/Km) with ibuprofen, ketoprofen, and others, compared to UGT1A3. These data indicate that UGT2B7 could be the major isoform involved in the glucuronidation of carboxylic acid compounds in humans.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090264 UDP-Glucuronosyltransferase 1A9 A PPAR alpha and PPAR gamma target gene. The enzyme plays an important role in elimination and DETOXIFICATION of drugs, XENOBIOTICS, and metabolizing endogenous compounds, including CATECHOLESTROGENS and FIBRATES. UDP-Glucuronosyltransferase, UGT1A9,UGT1A9 Protein,Uridine Diphosphate-Glucuronosyltransferase 1A9,1A9, UDP-Glucuronosyltransferase,1A9, Uridine Diphosphate-Glucuronosyltransferase,Protein, UGT1A9,UDP Glucuronosyltransferase, UGT1A9,UGT1A9 UDP-Glucuronosyltransferase
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013777 Tetrazoles

Related Publications

Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
December 1997, Drug metabolism and disposition: the biological fate of chemicals,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
December 2008, Chemosphere,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
January 2009, Drug metabolism and pharmacokinetics,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
October 2005, Drug metabolism and disposition: the biological fate of chemicals,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
January 2011, Drug metabolism and pharmacokinetics,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
September 2018, Expert opinion on drug metabolism & toxicology,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
September 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
December 2001, The Journal of pharmacology and experimental therapeutics,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
October 2012, Xenobiotica; the fate of foreign compounds in biological systems,
Kayo Sakaguchi, and Mitchell Green, and Nicholas Stock, and Thomas S Reger, and Jasmine Zunic, and Christopher King
May 2001, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!